Cargando…

PET imaging of occult tumours by temporal integration of tumour-acidosis signals from pH-sensitive (64)Cu-labelled polymers

Owing to the diversity of cancer types and to the spatiotemporal heterogeneity of tumour signals, high-resolution imaging of occult malignancy is challenging. (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) allows for near-universal cancer detection, yet in many clinical scenarios...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Gang, Zhao, Tian, Wang, Chensu, Nham, Kien, Xiong, Yahong, Gao, Xiaofei, Wang, Yihui, Hao, Guiyang, Ge, Woo-Ping, Sun, Xiankai, Sumer, Baran D., Gao, Jinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928453/
https://www.ncbi.nlm.nih.gov/pubmed/31235828
http://dx.doi.org/10.1038/s41551-019-0416-1
Descripción
Sumario:Owing to the diversity of cancer types and to the spatiotemporal heterogeneity of tumour signals, high-resolution imaging of occult malignancy is challenging. (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) allows for near-universal cancer detection, yet in many clinical scenarios it is hampered by false positives. Here, we report a method for the amplification of imaging contrast in tumours via the temporal integration of the imaging signals triggered by tumour acidosis. The method exploits the catastrophic disassembly, at the acidic pH of the tumour milieu, of pH-sensitive positron-emitting neutral copolymer micelles into polycationic polymers, which are then internalized and retained by the cancer cells. PET imaging of the (64)Cu-labelled polymers detected small occult tumours (10–20 mm(3)) in the brain, head, neck and breast of mice at much higher contrast than FDG, (11)C-methionine and pH-insensitive (64)Cu-labelled nanoparticles. We also show that the pH-sensitive probes reduce false-positive detection rates in a mouse model of non-cancerous lipopolysaccharide-induced inflammation. This macromolecular strategy for integrating tumour acidosis should enable improved cancer detection, surveillance and staging.